ACE2 functions a negative regulator of the RAS by metabolizing Ang II into the beneficial peptide Ang-(1-7); this important biochemical and physiological property is being harnessed as a potential therapeutic target in patients with cardiovascular diseases. Here, ACE2 is linked to cardiovascular disorder.